What’s Next for the Ischemic Stroke Market? Brett Wall, SVP and President of Brain Therapies at Medtronic, Weighs In

article image

New data documenting the benefits of endovascular clot removal for ischemic stroke, even in patients who present as late as 24-hours after stroke onset, have opened up endovascular thrombectomy to a much larger patient pool and raised the stakes for companies targeting this space. Even so, competitors would be well-advised to take a page from Medtronic and keep a close eye on new innovations in this fast-moving field.

A number of clinical studies have now documented the benefits of mechanical thrombectomy (clot retrievers and aspiration devices) in carefully selected patients suffering from a large-vessel ischemic stroke, even those who present up to 24 hours after stroke onset.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: